Nerve Decompression for Ulcer Recurrence Avoidance (DURA)
DURA
A Prospective Study of Recurrence Risk in Diabetic Foot Ulceration After Nerve Decompression
2 other identifiers
interventional
120
1 country
6
Brief Summary
Anecdotal reports and scientific literature suggest that the risk of recurrence of diabetic foot ulcers can be minimized by nerve decompression procedures at anatomic sites of nerve pinching and entrapment. Historical risk of 25% annually has been reported to decrease by \>80% to under 5% yearly. Since an open wound precedes the large majority (85%) of amputations in diabetes, avoidance of ulcer recurrences is important. This study tests the current academic opinion that nerve decompression will not decrease ulcer recurrence risk. Null hypothesis: nerve decompression will not decrease diabetic foot ulcer recurrence risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2013
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2013
CompletedFirst Posted
Study publicly available on registry
January 7, 2013
CompletedStudy Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedJune 26, 2015
June 1, 2015
3.5 years
January 3, 2013
June 25, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
occurrence of plantar foot ulceration wound
Non- traumatic pressure wound or ulcer appearance during the study.
2 years post-enrollment or post-op
Secondary Outcomes (2)
occurrence of delayed wound healing
3 months post nerve decompression
Visual Analog Pain Score
2 years
Other Outcomes (7)
any amputation
24 months, 2 years
surgical wound infection
3 months
non-surgical foot infection
24 months
- +4 more other outcomes
Study Arms (2)
healed DFU control arm
PLACEBO COMPARATORclinic-specific usual "best care"
healed DFU surgical intervention
EXPERIMENTALclinic-specific "best care" plus nerve decompression at 4 known sites of lower leg fibro-osseous entrapment
Interventions
surgical decompression involves surgical division or incision of perineural fibrous or fibro-osseous tunnel tissues which pinch, choke, compress or sharply deviate nerve trunks.
Eligibility Criteria
You may qualify if:
- Type 1 or Type 2 Diabetes Mellitus
- Diabetic sensorimotor peripheral neuropathy
- Recently healed plantar neuropathic Diabetic Foot Ulcer (\< 18 months)
- At least one palpable foot or ankle pulse or ABI\>0.8 bilaterally.
- Recent Hgb A1c \< 9.0%
- Ankle edema absent or mild
You may not qualify if:
- Ischemic peripheral vascular disease or ankle-brachial index (ABI)\<0.8
- History of peripheral vascular arterial surgery
- History of peripheral nerve or lumbar disc surgery
- alcohol abuse(more than 2 drinks/day)
- untreated thyroid disorders
- B12 or Folate deficiency
- spondyloarthropathies
- hepatic disease
- advanced renal disease
- current lumbosacral radiculopathy or nerve compression
- toxin exposure including chemotherapeutic agents
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Barrett Foot & Ankle Institute
Phoenix, Arizona, 85024, United States
Richard P. Jacoby
Scottsdale, Arizona, 85251, United States
Southern Arizona Limb Salvage Alliance,
Tucson, Arizona, 85724-5072, United States
Andrew Rader, DPM
Jasper, Indiana, 47546, United States
Damien Dauphinee
Denton, Texas, 76210, United States
Maria Buitrago, DPM
Houston, Texas, 77092, United States
Related Publications (8)
Aszmann O, Tassler PL, Dellon AL. Changing the natural history of diabetic neuropathy: incidence of ulcer/amputation in the contralateral limb of patients with a unilateral nerve decompression procedure. Ann Plast Surg. 2004 Dec;53(6):517-22. doi: 10.1097/01.sap.0000143605.60384.4e.
PMID: 15602245BACKGROUNDDellon AL. Preventing foot ulceration and amputation by decompressing peripheral nerves in patients with diabetic neuropathy. Ostomy Wound Manage. 2002 Sep;48(9):36-45.
PMID: 12271732BACKGROUNDDellon AL. Neurosurgical prevention of ulceration and amputation by decompression of lower extremity peripheral nerves in diabetic neuropathy: update 2006. Acta Neurochir Suppl. 2007;100:149-51. doi: 10.1007/978-3-211-72958-8_32.
PMID: 17985566BACKGROUNDNickerson DS. Low recurrence rate of diabetic foot ulcer after nerve decompression. J Am Podiatr Med Assoc. 2010 Mar-Apr;100(2):111-5. doi: 10.7547/1000111.
PMID: 20237362BACKGROUNDDellon AL, Muse VL, Nickerson DS, Akre T, Anderson SR, Barrett SL, Biddinger KR, Bregman PJ, Bullard BP, Dauphinee DM, DeJesus JM, DeJesus RA, Ducic I, Dunkerly J, Galina MR, Hung V, Ichtertz DR, Kutka MF, Jacoby RP, Johnson JB, Mader DW, Maloney CT Jr, Mancuso PJ, Martin RC, Martin RF, McDowel BA, Rizzo VJ, Rose M, Rosson GD, Shafiroff BB, Steck JK, Stolarski RG, Swier P, Wellens-Bruschayt TA, Wilke B, Williams EH, Wood MA, Wood WA, Younes MP, Yuksel F. Prevention of ulceration, amputation, and reduction of hospitalization: outcomes of a prospective multicenter trial of tibial neurolysis in patients with diabetic neuropathy. J Reconstr Microsurg. 2012 May;28(4):241-6. doi: 10.1055/s-0032-1306372. Epub 2012 Mar 12.
PMID: 22411624BACKGROUNDDellon AL. A cause for optimism in diabetic neuropathy. Ann Plast Surg. 1988 Feb;20(2):103-5. doi: 10.1097/00000637-198802000-00001. No abstract available.
PMID: 3355053BACKGROUNDDellon AL. Treatment of symptomatic diabetic neuropathy by surgical decompression of multiple peripheral nerves. Plast Reconstr Surg. 1992 Apr;89(4):689-97; discussion 698-9.
PMID: 1546082BACKGROUNDRankin TM, Miller JD, Gruessner AC, Nickerson DS. Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration. J Diabetes Sci Technol. 2015 Jul;9(4):873-80. doi: 10.1177/1932296815584796. Epub 2015 Jun 8.
PMID: 26055081BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
D. Scott Nickerson, MD
NE Wyoming Wound Care Center, consultant
- PRINCIPAL INVESTIGATOR
Stephen L. Barrett, DPM
Barrett Foot & Ankle Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2013
First Posted
January 7, 2013
Study Start
June 1, 2013
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
June 26, 2015
Record last verified: 2015-06